BrCA panel – BrCA1 & BrCA2
R9 760
Screens the two most clinically significant genes in hereditary breast cancer. Informs treatment planning, surgical decisions, and cascade testing within families.
Comprehensive BRCA1/BRCA2 gene panel
A targeted panel screening the two most common genes implicated in familial breast cancer, performed on blood or tumour samples. This test supports treatment planning and prognosis, and is also useful in other cancers with a suspected HRR mechanism.
- Blood sample (EDTA tube, drawn by a registered phlebotomist), saliva, or tumour sample
- Screens the 2 most common breast cancer genes (BRCA1/BRCA2)
- Relevant for cancers with suspected HRR aetiology
- Definitive result reported per gene screened
- Supports treatment planning and prognosis
Be the first to review “BrCA panel – BrCA1 & BrCA2”
Related products
Whole genome sequencing
R15 500
Oncomine Myeloid Assay (OMA)
R21 750
Nutrigenomics Premier
R6 850
Microbiome test
R5 900
DPYD Test
R4 650
Nutrigenomics Standard
R3 900
Familial mutation
R1 400
PGx Live
R7 500
Reviews
There are no reviews yet.